NAVIDEA BIOPHARMACEUTICALS, INC. (CIK: 0000810509) EDGAR, Information, Filings... CompaniesBIO.Com

NAVIDEA BIOPHARMACEUTICALS, INC.

Mailing address
4995 BRADENTON AVENUE, SUITE 240, DUBLIN, Delaware, 43017
Phone
6147937500
State location
Ohio
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

NAVIDEA BIOPHARMACEUTICALS, INC. (CIK: 0000810509) is an American company incorporated in the state of Ohio. Head office is located at 4995 BRADENTON AVENUE, SUITE 240, DUBLIN, Ohio, 43017. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. NAVIDEA BIOPHARMACEUTICALS, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

NEOPROBE CORP from 1995-10-Feb to 2011-30-Dec

Owner	Filings	Transaction Date	Type of Owner
Dais Craig	0001990095	Jul-28-2023	officer: Chief Financial Officer
Moss Dana J	0001985665	Jul-11-2023	director
Stefanelli Jill	0001980919	Jun-01-2023	director
Wilson Joshua M.	0001746168	Sep-30-2022	director
Scott John K Jr.	0001753763	Nov-15-2021	director, 10 percent owner
FARB THOMAS F	0001255671	Oct-07-2021	director
Winkler Agnieszka	0001353343	Oct-07-2021	director
Mikhail Michel	0001886391	Oct-01-2021	officer: Chief Regulatory Officer
CAPPELLO ALEXANDER L	0001193532	Jul-09-2021	director
Bhalla Amit	0001861065	May-04-2021	director
Witter Malcolm G	0001838283	Dec-28-2020	director
Kaufman Joel H.	0001831425	Nov-04-2020	officer: Chief Business Officer
Rosol Michael Stanley	0001762349	Dec-17-2018	officer: Chief Medical Officer
Cutler Adam D.	0001722673	Dec-01-2018	director
Rouan Sarah Kathryn	0001761366	Dec-01-2018	director
Bruck Claudine	0001733680	Mar-05-2018	director
RICE YEHUDA MICHAEL	0001674405	May-04-2016	director
Latkin Jed	0001554593	Apr-20-2016	officer: Interim COO
Fiorino Anthony S.	0001608901	Mar-23-2016	director
Greene Mark I	0001671323	Mar-23-2016	director
Tomblyn Michael	0001648504	Jul-02-2015	officer: SVP, Chief Med. Officer
GUETH ANTON	0001274940	Jun-01-2015	director
Cope Frederick O	0001456549	Mar-26-2015	officer: Senior VP and CSO
Klima Thomas J	0001629278	Jan-01-2015	officer: SVP and Chief Comm. Officer
GOLDBERG MICHAEL M	0000905011	Nov-10-2014	director
KARSEN PERRY A	0001260573	Nov-10-2014	director
DRAKE PETER F	0001267854	Nov-10-2014	director
Rowinsky Eric K	0001318886	Nov-10-2014	director
Troup Gordon A	0001441122	Nov-10-2014	director
Gonzalez Ricardo J	0001621173	Oct-13-2014	officer: Chief Executive Officer
LANDESMAN URI	0001120642	Aug-12-2014	10 percent owner
Nordlicht Mark	0001339643	Aug-12-2014	10 percent owner
Platinum Management (NY) LLC	0001368616	Aug-12-2014	10 percent owner
Platinum Partners Liquid Opportunity Master Fund L.P.	0001476165	Aug-12-2014	10 percent owner
Platinum Liquid Opportunity Management (NY) LLC	0001582140	Aug-12-2014	10 percent owner
FORD BRENDAN A	0001236444	Mar-15-2013	director
Tulip Thomas H.	0001528192	Mar-15-2013	officer: EVP & Chief Business Officer
Regan William J.	0001559381	Mar-15-2013	officer: SVP-Global Regulatory Strategy
Reininger Cornelia	0001559878	Nov-01-2012	officer: SVP & Chief Medical Officer
Platinum Partners Value Arbitrage Fund, LP	0001299265	Aug-26-2012	10 percent owner
Platinum-Montaur Life Sciences, LLC	0001404598	Aug-26-2012	10 percent owner
JONES JESS	0001490512	Apr-19-2011	director
PYKETT MARK JEROME	0001278271	Nov-15-2010	officer: EVP
Johnson Owen E	0001408298	Jul-26-2007	director
Rash Douglas L	0001312509	Jan-01-2005	officer: Vice President, Marketing
JAY JEFFREY R	0001239607	Dec-14-2004	10 percent owner
GREAT POINT PARTNERS LLC	0001281446	Dec-14-2004	10 percent owner
Blair Anthony K	0001297970	Jul-02-2004	officer: VP-Manufacturing & Operations
Aschinger Carl J Jr	0001293742	Jun-09-2004	director
Bland Kirby I	0001292444	May-21-2004	director
KATZ NANCY E	0001189692	Jan-07-2004	director
AVITAL REUVEN	0001195756	Jan-07-2004	director
BUPP DAVID C	0001195757	Jan-07-2004	director, officer: CEO and President
BROWN RODGER A	0001195759	Jan-07-2004	officer: Vice President
BOSCH CARL M	0001195760	Jan-07-2004	officer: VP - Instrument Development
KREVANS JULIUS R	0001195763	Jan-07-2004	director
LARSON BRENT L	0001195766	Jan-07-2004	officer: VP Finance and CFO
MILLER FRED B	0001195770	Jan-07-2004	director
WHITLEY J FRANK	0001195771	Jan-07-2004	director
LINDER RICHARD N JR	0001268532	Nov-01-2003	officer: VP Sales & Marketing

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NAVIDEA BIOPHARMACEUTICALS, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-24-010817 (34 Act) Size: KB	Feb-05-2024	005-43603 24597683
EFFECT	Document	Acc-no: 9999999995-24-000259 (33 Act) Size: KB	Jan-31-2024	333-274246 24584880
EFFECT	Document	Acc-no: 9999999995-24-000255 (33 Act) Size: KB	Jan-31-2024	333-262691 24584872
EFFECT	Document	Acc-no: 9999999995-24-000254 (33 Act) Size: KB	Jan-31-2024	333-252847 24584870
EFFECT	Document	Acc-no: 9999999995-24-000253 (33 Act) Size: KB	Jan-31-2024	333-248404 24584869
EFFECT	Document	Acc-no: 9999999995-24-000252 (33 Act) Size: KB	Jan-31-2024	333-235762 24584867
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002320 (33 Act) Size: KB	Jan-26-2024	333-276266 24569299
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002319 (33 Act) Size: KB	Jan-26-2024	333-268956 24569296
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002318 (33 Act) Size: KB	Jan-26-2024	333-250078 24569291
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002317 (33 Act) Size: KB	Jan-26-2024	333-228960 24569287
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001437749-24-002316 (33 Act) Size: KB	Jan-26-2024	333-235762 24569286
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002315 (33 Act) Size: KB	Jan-26-2024	333-198716 24569281
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001437749-24-002314 (33 Act) Size: KB	Jan-26-2024	333-248404 24569277
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002313 (33 Act) Size: KB	Jan-26-2024	333-238329 24569274
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001437749-24-002312 (33 Act) Size: KB	Jan-26-2024	333-252847 24569266
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002311 (33 Act) Size: KB	Jan-26-2024	333-217814 24569264
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001437749-24-002310 (33 Act) Size: KB	Jan-26-2024	333-274246 24569260
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002309 (33 Act) Size: KB	Jan-26-2024	333-158323 24569211
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001437749-24-002308 (33 Act) Size: KB	Jan-26-2024	333-262691 24569206
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-24-002307 (33 Act) Size: KB	Jan-26-2024	333-130636 24569204

Recent 20 filings. View all NAVIDEA BIOPHARMACEUTICALS, INC. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

NAVIDEA BIOPHARMACEUTICALS, INC. overview
NAVIDEA BIOPHARMACEUTICALS, INC. job
NAVIDEA BIOPHARMACEUTICALS, INC. stock
NAVIDEA BIOPHARMACEUTICALS, INC. ownership
NAVIDEA BIOPHARMACEUTICALS, INC. CEO
NAVIDEA BIOPHARMACEUTICALS, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.